Trivarx Ltd

AU:TRI Australia Health Information Services
Market Cap
$15.00 Million
AU$24.23 Million AUD
Market Cap Rank
#27839 Global
#696 in Australia
Share Price
AU$0.02
Change (1 day)
-4.55%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$9.44
Categories
Companies in Australia Health Information Services Technology
About

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more

Trivarx Ltd (TRI) - Net Assets

Latest net assets as of June 2025: AU$12.65 Million AUD

Based on the latest financial reports, Trivarx Ltd (TRI) has net assets worth AU$12.65 Million AUD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$13.48 Million) and total liabilities (AU$831.22K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$12.65 Million
% of Total Assets 93.84%
Annual Growth Rate 3.12%
5-Year Change -22.93%
10-Year Change 48.95%
Growth Volatility 71.82

Trivarx Ltd - Net Assets Trend (2001–2025)

This chart illustrates how Trivarx Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Trivarx Ltd (2001–2025)

The table below shows the annual net assets of Trivarx Ltd from 2001 to 2025.

Year Net Assets Change
2025-06-30 AU$12.65 Million +31.47%
2024-06-30 AU$9.62 Million +57.00%
2023-06-30 AU$6.13 Million -13.74%
2022-06-30 AU$7.11 Million -56.71%
2021-06-30 AU$16.42 Million +30.19%
2020-06-30 AU$12.61 Million +46.54%
2019-06-30 AU$8.60 Million -38.48%
2018-06-30 AU$13.99 Million +5.05%
2017-06-30 AU$13.31 Million +56.74%
2016-06-30 AU$8.49 Million -6.77%
2015-06-30 AU$9.11 Million +236.17%
2014-06-30 AU$2.71 Million +6.78%
2013-06-30 AU$2.54 Million +3.84%
2012-06-30 AU$2.44 Million +107.58%
2011-06-30 AU$1.18 Million +7.29%
2010-06-30 AU$1.10 Million -55.41%
2009-06-30 AU$2.46 Million -56.63%
2008-06-30 AU$5.68 Million +201.61%
2007-06-30 AU$1.88 Million -16.68%
2006-06-30 AU$2.26 Million -49.09%
2005-06-30 AU$4.44 Million -8.67%
2004-06-30 AU$4.86 Million -5.68%
2003-06-30 AU$5.15 Million -14.89%
2002-06-30 AU$6.05 Million +0.06%
2001-06-30 AU$6.05 Million --

Equity Component Analysis

This analysis shows how different components contribute to Trivarx Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 10210906700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$109.96 Million 869.08%
Other Comprehensive Income AU$6.60 Million 52.20%
Total Equity AU$12.65 Million 100.00%

Trivarx Ltd Competitors by Market Cap

The table below lists competitors of Trivarx Ltd ranked by their market capitalization.

Company Market Cap
Gem Diamonds Limited
PINK:GMDMF
 		$11.72 Million
Barloworld Ltd
JSE:BAW
 		$11.72 Million
Union Petrochemical Public Company Limited
BK:UKEM
 		$11.72 Million
Silver Ridge Holdings Bhd
KLSE:0129
 		$11.73 Million
Autopedia Sukses Lestari Tbk PT
JK:ASLC
 		$11.72 Million
Luo Lih Fen Holding Co Ltd
TW:6666
 		$11.72 Million
Kutcho Copper Corp
OTCQX:KCCFF
 		$11.71 Million
Community Investors Bancorp Inc
PINK:CIBN
 		$11.71 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Trivarx Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 9,882,827 to 12,652,377, a change of 2,769,550 (28.0%).
  • Net loss of 943,231 reduced equity.
  • Share repurchases of 2,734,320 reduced equity.
  • Other comprehensive income increased equity by 398,609.
  • Other factors increased equity by 6,048,492.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$-943.23K -7.45%
Share Repurchases AU$2.73 Million -21.61%
Other Comprehensive Income AU$398.61K +3.15%
Other Changes AU$6.05 Million +47.81%
Total Change AU$- 28.02%

Book Value vs Market Value Analysis

This analysis compares Trivarx Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.82x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.00x to 0.82x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-06-30 AU$9.54 AU$0.02 x
2002-06-30 AU$5.57 AU$0.02 x
2003-06-30 AU$3.41 AU$0.02 x
2004-06-30 AU$2.52 AU$0.02 x
2005-06-30 AU$2.05 AU$0.02 x
2006-06-30 AU$0.75 AU$0.02 x
2007-06-30 AU$0.48 AU$0.02 x
2008-06-30 AU$0.95 AU$0.02 x
2009-06-30 AU$0.38 AU$0.02 x
2010-06-30 AU$0.16 AU$0.02 x
2011-06-30 AU$0.10 AU$0.02 x
2012-06-30 AU$0.12 AU$0.02 x
2013-06-30 AU$0.09 AU$0.02 x
2014-06-30 AU$0.08 AU$0.02 x
2015-06-30 AU$0.18 AU$0.02 x
2016-06-30 AU$0.08 AU$0.02 x
2017-06-30 AU$0.11 AU$0.02 x
2018-06-30 AU$0.07 AU$0.02 x
2019-06-30 AU$0.04 AU$0.02 x
2020-06-30 AU$0.01 AU$0.02 x
2021-06-30 AU$0.22 AU$0.02 x
2022-06-30 AU$0.07 AU$0.02 x
2023-06-30 AU$0.04 AU$0.02 x
2024-06-30 AU$0.03 AU$0.02 x
2025-06-30 AU$0.03 AU$0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Trivarx Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -7.45%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -83.55%
  • • Asset Turnover: 0.08x
  • • Equity Multiplier: 1.07x
  • Recent ROE (-7.45%) is above the historical average (-76.09%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 3.00% 133.08% 0.02x 1.12x AU$-436.18K
2002 12.59% 487.25% 0.02x 1.16x AU$155.86K
2003 1.55% 138.52% 0.01x 1.06x AU$-435.26K
2005 -41.21% -1617.34% 0.02x 1.05x AU$-2.27 Million
2006 -34.44% -4533.35% 0.01x 1.08x AU$-1.00 Million
2007 -75.98% -17111.58% 0.00x 1.10x AU$-1.62 Million
2008 -82.06% -5117.77% 0.01x 1.09x AU$-5.22 Million
2009 -123.33% 0.00% 0.00x 1.11x AU$-3.28 Million
2010 -300.80% -226748.21% 0.00x 1.28x AU$-3.41 Million
2011 -273.46% -1095.12% 0.09x 2.78x AU$-3.34 Million
2012 -136.11% -6349.51% 0.01x 2.24x AU$-3.57 Million
2013 -43.21% -5703.14% 0.00x 2.13x AU$-1.35 Million
2014 -15.80% 0.00% 0.00x 1.86x AU$-699.36K
2015 -86.95% -3024.36% 0.02x 1.67x AU$-8.83 Million
2016 -68.57% -31483.09% 0.00x 2.11x AU$-6.67 Million
2017 -73.49% -42359.62% 0.00x 1.45x AU$-11.12 Million
2018 -116.54% -7956.14% 0.01x 1.36x AU$-17.70 Million
2019 -76.55% -1806.51% 0.03x 1.55x AU$-7.45 Million
2020 -37.28% -3521.24% 0.01x 1.11x AU$-5.96 Million
2021 -9.06% -1462.38% 0.01x 1.06x AU$-3.13 Million
2022 -178.95% -31759.35% 0.00x 1.19x AU$-13.43 Million
2023 -49.55% -14132.93% 0.00x 1.25x AU$-3.75 Million
2024 -12.52% -138.48% 0.08x 1.09x AU$-2.23 Million
2025 -7.45% -83.55% 0.08x 1.07x AU$-2.21 Million

Industry Comparison

This section compares Trivarx Ltd's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $19,142,795
  • Average return on equity (ROE) among peers: -52.12%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Trivarx Ltd (TRI) AU$12.65 Million 3.00% 0.07x $11.72 Million
Adheris Health Limited (AHE) $51.58 Million 1.54% 0.92x $119.94
Alcidion Group Ltd (ALC) $6.57 Million -38.71% 0.23x $60.88 Million
ARTRYA Ltd (AYA) $40.64 Million -42.21% 0.08x $148.36 Million
Blinklab Ltd (BB1) $6.48 Million -27.04% 0.06x $39.10 Million
Beamtree Holdings Ltd (BMT) $29.22 Million 1.31% 0.10x $18.03 Million
Cogstate Ltd (CGS) $29.02 Million 24.18% 1.36x $124.86 Million
Careteq Ltd (CTQ) $3.55 Million -121.85% 1.13x $621.63K
Doctor Care Anywhere Group Plc (DOC) $12.29 Million -179.31% 0.79x $21.76 Million
Echoiq Ltd (EIQ) $6.77 Million -79.92% 0.22x $168.60 Million
Emyria Ltd (EMD) $5.31 Million -59.24% 0.25x $11.75 Million